| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fe34f62c406f2ac6fece004483b4c2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b8b5d5496a428be9b38615599f1d4f6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-24 |
| filingDate |
2000-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c1dc53ffee2ec90c47ae02c595373b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0b5b23aa5d2bc2d646302b92ab4d8cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ba7b201c8b017bf380fc6a3229ff925 |
| publicationDate |
2001-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1077072-A2 |
| titleOfInvention |
In vitro process for the preparation of heart valve or vessel prothese |
| abstract |
The invention relates to an in vitro method for producing homologous heart valves and vessels.n n n So far, patients suffering from heart valve dysfunction have either been mechanicalnHeart valve or a biological valve from a human ornimplanted non-human donors. However, these flaps have significantnDisadvantages such as the need for lifelong anticoagulation with thenRisk of hemorrhagic complications, a tendency to degeneration and thenRisk of an immune reaction. In addition, none of the previously known flapsne.g. adapt by changing hearts. Comparablenbig problems arise when using vial homografts and plastic vesselsnas a blood vessel replacement.n n n With the method according to the invention, homologous heart valves and blood vessels can be made available which or their wall are made up of an essentially connective tissue core and a superficial endothelial cell layer and thus have a structure analogous to the natural heart valve or the natural vessel. The disadvantages of the known heart valve and vascular prostheses are avoided by the heart valve and blood vessel prostheses according to the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102010026369-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011098367-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004112858-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2267114-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005107642-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2431666-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2130905-A1 |
| priorityDate |
1999-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |